The JAVELIN Bladder 100 phase III clinical trial demonstrates that treatment with immunotherapy avelumab plus…
eabramovichJune 16, 2020
Adaptive Biotechnologies Corp. (Nasdaq: ADPT) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing…
emcguinnJune 12, 2020
In early March, developmental biologist Lee Niswander’s lab at the University of Colorado Boulder had…
eabramovichJune 11, 2020
Scientists from the Seattle Children’s Research Institute and the Benaroya Research Institute have found a potential…
emcguinnJune 11, 2020
It is increasingly clear that the human microbiome — the trillions of microbes that live in and…
eabramovichJune 9, 2020
Over the last four years, Benaroya Research Institute at Virginia Mason (BRI) and Seattle Children’s Research Institute (SCRI) have…
eabramovichJune 9, 2020
This week, a vaccine candidate for the novel coronavirus hit a new milestone and entered the…
emcguinnJune 8, 2020
Athira Pharma changed its name last year to reflect its focus on regenerative medicine. Now,…
emcguinnJune 8, 2020
Seattle’s Infectious Disease Research Institute is working with Houston’s Baylor College of Medicine to multiply the doses of a…
emcguinnJune 5, 2020
